The value of axillary ultrasonography in predicting non-sentinel lymph node metastasis in breast cancer patients

Lijing GUO,Huiyuan WANG,Bin LUO
2015-01-01
Abstract:Objective:Sentinel lymph node (SLN) biopsy is considered to be the standard procedure in staging the axilla status in breast cancer patients. Axillary lymph node dissection (ALND) may be an over-treatment for patients with positive SLN alone while without non-sentinel lymph nodes (non-SLN) metastasis. The purpose of this study is to evaluate whether axillary ultrasonography (AUS) can predict involvement of non-SLN. Methods: The data from the primary invasive breast cancer patients who were operated by one surgeon from January, 2008 through December, 2012 were retrospectively reviewed. All the recruited patients received preoperative AUS but neither neo-adjuvant chemotherapy nor endocrine therapy. The results of AUS were compared with the pathological reports of ALND or SLN biopsy. Results:One hundred and iffty-four patients were included, in which 117 patients (76.0%) had negative AUS ifnding. One hundred and two patients (66.2%) underwent SLN biopsy at time of deifnitive surgery. Fifteen patients with positive SLN underwent ALND, in which 7 patients had negative non-SLN. Among the 117 patients with negative AUS ifnding, there were 113 cases (96.6%) with a negative non-SLN. The sensitivity,speciifcity, negative predictive value, and accuracy of AUS in predicting non-SLN involvement were 81.8%, 85.6%, 96.6%, and 85.1%, respectively. Conclusion:A negative AUS may be a predictor of noninvolvement of non-SLN in patients with primary invasive breast cancer. Patients with negative AUS may undergo SLN biopsy only, regardless of the SLN status.
What problem does this paper attempt to address?